Rarebase is enabling a better life for the 400 million people living with rare disease. With a product engine designed to discover treatments for hundreds of monogenic diseases simultaneously, Rarebase is focused on the largest untapped drug discovery opportunity in human health: rare diseases. Rarebase has already uncovered potential treatments for hundreds of rare diseases. The company has also built a “drug-gene atlas” to enable AI-driven drug discovery.

Biotechnology

Health Care

Life Sciences

Therapeutics

Rarebase

Christopher Moxham

Nicole Perfito

Deanna Wong

Clayton Mellina

Discovery and Research Biology

Leadership Team

Teams at Rarebase

Discovery and Research Biology

Leadership Team